Gemcitabine in combination with new platinum compounds: An update

ONCOLOGY

Volumn 15, Issue 3 SUPPL. 6, 2001, Pages 13-17

  Gandara, David R ^a   Edelman, Martin J ^b   Lara, Primo N ^c   Lau, Derick H M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; PLATINUM DERIVATIVE;

HUMAN; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; HUMAN; PLATINUM COMPOUNDS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035292235     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alban KS, Crowley JJ, LeBlanc M, et al: Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol 9:1618-1626, 1991.
2. Gandara DR, Crowley J, Livingston RB, et al: Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group. J Clin Oncol 11:873-878, 1993.
3. Klastersky J, Saulier JP, Bureau G, et al: Cisplatin versus cisplatin plus etoposide in the treatment of advanced non small cell lung cancer. J Clin Oncol 7:1087-1092, 1989.
4. Sandler AB, Nemunaitis J, Denham C, et al: Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18:122-130, 2000.
5. Crino L, Scagliotti GV, Ricci S, et al: Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 17:3522-3530, 1999.
6. Cardenal F, Lopez-Cabrerizo MP, Anton A, et al: Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 17:12-18, 1999.
7. Klastersky J, Sculier JP, Laccroiz H, et al: A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861. J Clin Oncol 8:1556-1562, 1990.
8. Ng EW, Sandler AB, Einhorn AB, et al: A phase II study of carboplatin plus gemcitabine in non-small-cell lung cancer (abstract 1801). Proc Am Soc Clin Oncol 17:468a, 1998.
9. Carrato A, Alberola V, Massuti B, et al: Combination of gemcitabine and carboplatin as first-line treatment in non-small-cell lung cancer (abstract 431P). Ann Oncol 9:89, 1998.
10. 9a. Carrato A, García-Gómez J, Alberola V, et al: Carboplatin in combination with gemcitabine in advanced non-small-cell lung cancer. Comparison of two consecutive phase II trials using different schedules (abstract 1922). Proc Am Soc Clin Oncol 18:498a, 1999.
11. Edelman MJ, Gandara DR: Sequential chemotherapy: Rationale and clinical trial design in advanced NSCLC. J Clin Lung Cancer 1:122-126, 1999.
12. Carmichael J, Allerheiligen S, Walling J: A phase II study of gemcitabine and carboplatin in non-small-cell lung cancer. Semin Oncol 23(suppl 10):55-59, 1996.
13. Page JD, Husein I, Saucer A, et al: Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and actuality. Biochemistry 29:1016-1024, 1990.
14. Monnet I, Brienza S, Hugret F: Phase II study of oxaliplatin in poor prognosis non-small-cell lung cancer. Eur J Cancer 34(7):1124-1127, 1998.
15. Mavroudis D, Kouroussis C, Kakolyris S, et al: A phase I study of the gemcitabine and oxaliplatin combination in patients with advanced solid tumors (abstract 842). Proc Am Soc Clin Oncol 18:2191, 1999.
16. Martinez J, Panizo A, Alonso MA, et al: Gemcitabine plus carboplatin in advanced non-small-cell lung cancer: A phase I trial. Proc Am Soc Clin Oncol 17:494a, 1998.